Despite Limitations, Gymnotic Delivery of Antisense Oligos Offers Benefits over Transfection

Gymnosis combines specifically modified antisense oligos with a cell's normal growth properties to achieve sequence-specific target knockdown without the need for transfection reagents or serum additives, according to its developers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.